-
Coding References
Learn
Solutions
- Subscription Options
HCPCS C Code Lookup
HCPCS C codes are reported by hospital outpatient departments under the Outpatient Prospective Payment System (OPPS), most often for pass-through drugs and biologicals paid separately from the procedure.
C9250
ARTISS- HCPCS Descriptor
- Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
- Manufacturer
- Baxter Healthcare
- Class
- Wound Care
- NDCs
- 3
2 ml per unit
View details
C9257
AVASTIN- HCPCS Descriptor
- Injection, bevacizumab, 0.25 mg
- Manufacturer
- Genentech
- Class
- Oncology
- NDCs
- 2
0.25 mg per unit
View details
C9462
BAXDELA- HCPCS Descriptor
- Injection, delafloxacin, 1 mg
- Manufacturer
- Melinta Therapeutics
- Class
- Antibiotic
- NDC
- 1
1 mg per unit
View details
C9047
CABLIVI- HCPCS Descriptor
- Injection, caplacizumab-yhdp, 1 mg
- Manufacturer
- Genzyme
- Class
- Hematology
- NDC
- 1
1 mg per unit
View details
C9046
COCAINE HCL- HCPCS Descriptor
- Cocaine hydrochloride nasal solution (goprelto), 1 mg
- Manufacturer
- Genus Lifesciences
- Class
- Anesthetic
- NDC
- 1
1 mg per unit
View details
C9313
Decnupaz- HCPCS Descriptor
- Injection, pivekimab sunirine-pvzy, 0.01 mg
- Manufacturer
- Abbvie
- Class
- Oncology
- NDC
- 1
Effective Oct 1, 2026
View details
C9312
Evdi- HCPCS Descriptor
- Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg
- Manufacturer
- Apotex
- Class
- Oncology
- NDC
- 1
Effective Oct 1, 2026
View details
C9818
Journavx- HCPCS Descriptor
- Suzetrigine, oral, 1 mg
- Manufacturer
- Vertex Pharmaceuticals
- Class
- Non-Opioid Analgesic
- NDCs
- 2
1 mg per unit
View details
C9460
KENGREAL- HCPCS Descriptor
- Injection, cangrelor, 1 mg
- Manufacturer
- Chiesi USA
- Class
- Hematology
- NDC
- 1
1 mg per unit
View details
C9143
Numbrino- HCPCS Descriptor
- Cocaine hydrochloride nasal solution (numbrino), 1 mg
- Manufacturer
- Omnivium Pharmaceuticals
- Class
- Anesthetic
- NDC
- 1
1 mg per unit
View details
C9101
Olinvyk- HCPCS Descriptor
- Injection, oliceridine, 0.1 mg
- Manufacturer
- Trevena
- Class
- Opioid Analgesic
- NDCs
- 3
0.1 mg per unit
View details
C9144
Posimir- HCPCS Descriptor
- Injection, bupivacaine (posimir), 1 mg
- Manufacturer
- Innocoll Pharmaceuticals
- Class
- Anesthetic
- NDC
- 1
1 mg per unit
View details
C9482
SOTALOL HCL- HCPCS Descriptor
- Injection, sotalol hydrochloride, 1 mg
- Manufacturer
- Altathera Pharmaceuticals
- Class
- Cardiology
- NDC
- 1
1 mg per unit
View details
C9488
VAPRISOL-5% DEXTROSE- HCPCS Descriptor
- Injection, conivaptan hydrochloride, 1 mg
- Manufacturer
- Cumberland Pharmacy
- Class
- Diuretic
- NDC
- 1
1 mg per unit
View details
C9254
Vimpat- HCPCS Descriptor
- Injection, lacosamide, 1 mg
- Manufacturer
- UCB Pharma
- Class
- Neurology
- NDC
- 1
1 mg per unit
View details
C9293
VORAXAZE- HCPCS Descriptor
- Injection, glucarpidase, 10 units
- Manufacturer
- BTG International
- Class
- Oncology
- NDC
- 1
10 units per unit
View details
C9310
Vykoura- HCPCS Descriptor
- Injection, leucovorin calcium (avyxa), 1 mg
- Manufacturer
- Avyxa Pharma
- Class
- Oncology
- NDCs
- 3
1 mg per unit
View details
C9311
Wainua- HCPCS Descriptor
- Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- Manufacturer
- Astrazeneca
- Class
- Genetic Disorder
- NDCs
- 2
Effective Oct 1, 2026
View details
C9152
ABILIFY ASIMTUFII- HCPCS Descriptor
- Injection, aripiprazole, (abilify asimtufii), 1 mg
- Manufacturer
- Otsuka America Pharmaceuticals Inc
- Class
- Psychiatric
- NDCs
- 2
Inactive December 31, 2023
View details
C9167
ADZYNMA- HCPCS Descriptor
- Injection, adamts13, recombinant-krhn, 10 iu
- Manufacturer
- Takeda Pharmaceuticals
- Class
- Hematology
- NDCs
- 2
Inactive June 30, 2024
View details
C9142
Alymsys- HCPCS Descriptor
- Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- Manufacturer
- Amneal Biosciences
- Class
- Oncology
- NDCs
- 2
Inactive December 31, 2022
View details
C9169
ANKTIVA- HCPCS Descriptor
- Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- Manufacturer
- Altor BioScience, LLC
- Class
- Oncology
- NDC
- 1
Inactive December 31, 2024
View details
C9145
APONVIE- HCPCS Descriptor
- Injection, aprepitant, (aponvie), 1 mg
- Manufacturer
- Heron Therapeutics
- Class
- Anti-Emetic
- NDC
- 1
Inactive March 31, 2026
View details
C9301
AUCATZYL- HCPCS Descriptor
- Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Autolus
- Class
- Oncology
- NDC
- 1
Inactive June 30, 2025
View details
C9159
BALFAXAR- HCPCS Descriptor
- Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity
- Manufacturer
- Octapharma
- Class
- Hematology
- NDCs
- 2
Inactive March 31, 2024
View details
C9153
BARHEMSYS- HCPCS Descriptor
- Injection, amisulpride, 1 mg
- Manufacturer
- Acacia Pharma
- Class
- Anti-Emetic
- NDCs
- 2
Inactive December 31, 2023
View details
C9172
BEQVEZ- HCPCS Descriptor
- Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- Manufacturer
- Pfizer
- Class
- Genetic Disorder
- NDCs
- 4
Inactive December 31, 2024
View details
C9300
BLUDIGO- HCPCS Descriptor
- Injection, indigotindisulfonate sodium, 1 mg
- Manufacturer
- Provepharm
- Class
- Imaging/Radiopharmaceutical
- NDC
- 1
Inactive June 30, 2025
View details
C9154
BRIXADI- HCPCS Descriptor
- Injection, buprenorphine extended-release (brixadi), 1 mg
- Manufacturer
- Braeburn Pharmaceutical
- Class
- Anti-Addiction
- NDCs
- 7
Inactive December 31, 2023
View details
C9248
CLEVIPREX- HCPCS Descriptor
- Injection, clevidipine butyrate, 1 mg
- Manufacturer
- Chiesi USA
- Class
- Cardiology
- NDCs
- 2
Inactive September 30, 2025
View details
C9166
COSENTYX- HCPCS Descriptor
- Injection, secukinumab, intravenous, 1 mg
- Manufacturer
- Novartis
- Class
- Immunology
- NDC
- 1
Inactive June 30, 2024
View details
C9174
DATROWAY- HCPCS Descriptor
- Injection, datopotamab deruxtecan-dlnk, 1 mg
- Manufacturer
- Daiichi Sankyo
- Class
- Oncology
- NDC
- 1
Inactive September 30, 2025
View details
C9160
DAXXIFY- HCPCS Descriptor
- Injection, daxibotulinumtoxina-lanm, 1 unit
- Manufacturer
- Revance Therapeutics
- Class
- Neurology
- NDC
- 1
Inactive March 31, 2024
View details
C9146
ELAHERE- HCPCS Descriptor
- Injection, mirvetuximab soravtansine-gynx, 1 mg
- Manufacturer
- Immunogen
- Class
- Oncology
- NDC
- 1
Inactive June 30, 2023
View details
C9165
ELREXFIO- HCPCS Descriptor
- Injection, elranatamab-bcmm, 1 mg
- Manufacturer
- Pfizer
- Class
- Oncology
- NDCs
- 2
Inactive March 31, 2024
View details
C9306
EMRELIS- HCPCS Descriptor
- Injection, telisotuzumab vedotin-tllv, 1 mg
- Manufacturer
- Abbvie
- Class
- Oncology
- NDCs
- 2
Inactive December 31, 2025
View details
C9094
ENJAYMO- HCPCS Descriptor
- Inj, sutimlimab-jome, 10 mg
- Manufacturer
- Bioverativ
- Class
- Hematology
- NDC
- 1
Inactive September 30, 2022
View details
C9155
EPKINLY- HCPCS Descriptor
- Injection, epcoritamab-bysp, 0.16 mg
- Manufacturer
- Genmab
- Class
- Oncology
- NDCs
- 2
Inactive December 31, 2023
View details
C9290
EXPAREL- HCPCS Descriptor
- Injection, bupivacaine liposome, 1 mg
- Manufacturer
- Pacira Pharmaceuticals
- Class
- Anesthetic
- NDCs
- 4
Inactive December 31, 2024
View details
C9161
EYLEA HD- HCPCS Descriptor
- Injection, aflibercept hd, 1 mg
- Manufacturer
- Regeneron Pharmaceuticals, Inc
- Class
- Ophthalmology
- NDC
- 1
Inactive March 31, 2024
View details
C9175
GRAFAPEX- HCPCS Descriptor
- Injection, treosulfan, 50 mg
- Manufacturer
- Medexus Pharma
- Class
- Oncology
- NDCs
- 2
Inactive September 30, 2025
View details
C9304
HYMPAVZI- HCPCS Descriptor
- Injection, marstacimab-hncq, 0.5 mg
- Manufacturer
- Pfizer
- Class
- Hematology
- NDC
- 1
Inactive June 30, 2025
View details
C9305
IMAAVY- HCPCS Descriptor
- Injection, nipocalimab-aahu, 3 mg
- Manufacturer
- Janssen
- Class
- Immunology
- NDC
- 1
Inactive December 31, 2025
View details
C9170
IMDELLTRA- HCPCS Descriptor
- Injection, tarlatamab-dlle, 1 mg
- Manufacturer
- Amgen
- Class
- Oncology
- NDCs
- 2
Inactive December 31, 2024
View details
C9147
IMJUDO- HCPCS Descriptor
- Injection, tremelimumab-actl, 1 mg
- Manufacturer
- Astrazeneca
- Class
- Oncology
- NDCs
- 2
Inactive June 30, 2023
View details
C9309
Itvisma- HCPCS Descriptor
- Injection, onasemnogene abeparvovec-brve, per treatment
- Manufacturer
- Novartis Gene Therapies
- Class
- Genetic Disorder
Inactive June 30, 2026
View details
C9162
IZERVAY- HCPCS Descriptor
- Injection, avacincaptad pegol, 0.1 mg
- Manufacturer
- Astellas Pharma
- Class
- Ophthalmology
- NDC
- 1
Inactive March 31, 2024
View details
C9308
KYXATA- HCPCS Descriptor
- Injection, carboplatin (avyxa), 1 mg
- Manufacturer
- Avyxa Pharma
- Class
- Oncology
- NDCs
- 2
Inactive March 31, 2026
View details
C9171
LUMISIGHT- HCPCS Descriptor
- Injection, pegulicianine, 1 mg
- Manufacturer
- Lumicell
- Class
- Imaging/Radiopharmaceutical
- NDC
- 1
Inactive December 31, 2024
View details
C9307
LYNOZYFIC- HCPCS Descriptor
- Injection, linvoseltamab-gcpt, 1 mg
- Manufacturer
- Regeneron Pharmaceuticals, Inc
- Class
- Oncology
- NDCs
- 2
Inactive March 31, 2026
View details
C9173
NYPOZI- HCPCS Descriptor
- Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- Manufacturer
- Tanvex Biopharma USA
- Class
- Oncology
- NDCs
- 4
Inactive June 30, 2025
View details
C9168
OMVOH- HCPCS Descriptor
- Injection, mirikizumab-mrkz, 1 mg
- Manufacturer
- Eli Lilly
- Class
- Gastroenterology
- NDCs
- 2
Inactive June 30, 2024
View details
C9157
QALSODY- HCPCS Descriptor
- Injection, tofersen, 1 mg
- Manufacturer
- Biogen
- Class
- Neurology
- NDC
- 1
Inactive December 31, 2023
View details
C9151
SYFOVRE- HCPCS Descriptor
- Injection, pegcetacoplan, 1 mg
- Manufacturer
- Apellis Pharmaceuticals
- Class
- Ophthalmology
- NDC
- 1
Inactive September 30, 2023
View details
C9163
TALVEY- HCPCS Descriptor
- Injection, talquetamab-tgvs, 0.25 mg
- Manufacturer
- Janssen
- Class
- Oncology
- NDCs
- 2
Inactive March 31, 2024
View details
C9148
TECVAYLI- HCPCS Descriptor
- Injection, teclistamab-cqyv, 0.5 mg
- Manufacturer
- Janssen
- Class
- Oncology
- NDCs
- 2
Inactive June 30, 2023
View details
C9149
TZIELD- HCPCS Descriptor
- Injection, teplizumab-mzwv, 5 mcg
- Manufacturer
- Provention Bio
- Class
- Immunology
- NDCs
- 3
Inactive June 30, 2023
View details
C9158
UZEDY- HCPCS Descriptor
- Injection, risperidone, (uzedy), 1 mg
- Manufacturer
- Teva
- Class
- Psychiatric
- NDCs
- 7
Inactive December 31, 2023
View details
C9303
VYLOY- HCPCS Descriptor
- Injection, zolbetuximab-clzb, 1 mg
- Manufacturer
- Astellas Pharma
- Class
- Oncology
- NDC
- 1
Inactive June 30, 2025
View details
C9089
Xaracoll- HCPCS Descriptor
- Bupivacaine, collagen-matrix implant, 1 mg
- Manufacturer
- Innocoll Pharmaceuticals
- Class
- Anesthetic
- NDCs
- 2
Inactive December 31, 2025
View details
C9150
XENOVIEW- HCPCS Descriptor
- Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- Manufacturer
- Polarean, Inc.
- Class
- Imaging/Radiopharmaceutical
- NDC
- 1
Inactive September 30, 2024
View details
C9164
YCANTH- HCPCS Descriptor
- Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- Manufacturer
- Verrica Pharmaceuticals
- Class
- Dermatology
- NDCs
- 3
Inactive March 31, 2024
View details
C9302
ZIIHERA- HCPCS Descriptor
- Injection, zanidatamab-hrii, 2 mg
- Manufacturer
- Jazz Pharmaceuticals
- Class
- Oncology
- NDC
- 1
Inactive June 30, 2025
View details
C9088
Zynrelef- HCPCS Descriptor
- Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
- Manufacturer
- Heron Therapeutics
- Class
- Anesthetic
- NDCs
- 3
Inactive September 30, 2025
View details
No codes match these filters.
